Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments

被引：0
|
作者：
Garcia, Jose Luis Rueda [1 ,2 ]
Benitez, Jose Manuel [3 ]
Rey, Iria Baston [4 ]
Sard, Margalida Calafat [5 ]
Ferrer, Cristina Suarez [1 ,2 ]
机构：
[1] Hosp Univ La Paz, Serv Gastroenterol, Unidad EII, Madrid, Spain
[2] Univ La Paz IdiPAZ, Grp Invest Enfermedades Gastrointestinales Inmunom, Inst Invest Hosp, Madrid, Spain
[3] Hosp Univ Reina Sofia, Unidad EII, IMIBIC, Serv Gastroenterol, Cordoba, Spain
[4] Complejo Hosp Univ Santiago De Compostela, Serv Gastroenterol, Unidad EII, Santiago De Compostela, Spain
[5] Hosp Badalona Germans Trias & Pujol, Serv Gastroenterol, Unidad EII, Badalona, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2025年 / 48卷 / 01期
关键词：
VENOUS THROMBOEMBOLISM; THERAPY; EVENTS; UPADACITINIB; METAANALYSIS; MORTALITY;
D O I：
10.1016/j.gastrohep.2024.502257
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] New treatments for venous thromboembolic disease
    Combe, S.
    JOURNAL DES MALADIES VASCULAIRES, 2011, 36 : S16 - S19
  • [32] Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study
    Bernstein, Charles N.
    Nugent, Zoann
    Singh, Harminder
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (07) : 1476 - 1484
  • [33] A Practical Approach to JAK Inhibitors for Inflammatory Bowel Disease in 2020
    Loftus, Edward, V
    PRACTICAL GASTROENTEROLOGY, 2020, 44 (05) : 36 - 40
  • [34] Incidence and risk factors for thromboembolic events in pediatric-onset inflammatory bowel disease: A French population-based study
    Richard, Nicolas
    Leroyer, Ariane
    Ley, Delphine
    Dupont, Claire
    Bertrand, Valerie
    Wils, Pauline
    Gower-Rousseau, Corine
    Turck, Dominique
    Guillon, Nathalie
    Sarter, Helene
    Savoye, Guillaume
    Fumery, Mathurin
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (02) : 584 - 594
  • [35] The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease
    Gupta, Nancy
    Papasotiriou, Sam
    Hanauer, Stephen
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1075 - 1089
  • [36] Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
    Sleutjes, Jasmijn A. M.
    van Lennep, Jeanine E. Roeters
    van der Woude, C. Janneke
    de Vries, Annemarie C.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [37] Incidence and risk factors for neoplasia in inflammatory bowel disease
    Garcia, Joana Lemos
    Rosa, Isadora
    da Silva, Joao Pereira
    Moleiro, Joana
    Claro, Isabel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (05) : 559 - 564
  • [38] Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Koutroumpakis, Efstratios I.
    Tsiolakidou, Georgia
    Koutroubakis, Ioannis E.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (05) : 461 - 468
  • [39] Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
    Catalan-Serra, Ignacio
    Brenna, Oystein
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (11) : 2597 - 2611
  • [40] Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
    Na, Soo-Young
    Moon, Won
    GUT AND LIVER, 2019, 13 (06) : 604 - 616
12345